OTHER NEWS - Nov. 18, 1994
From Times Staff and Wire Reports
A federal advisory committee recommended against Food and Drug Administration approval of the Proctor & Gamble drug Didrocal for treating post-menopausal osteoporosis. . . . First Chicago Corp. disclosed that it lost $7.2 million after rescuing several mutual funds with investments in risky derivatives securities that went sour.
